Cefprozil PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Cefprozil PCD pharma franchise company offering 4 WHO-GMP certified formulations available in Dry Syrup, Tablets. We provide monopoly-based distribution rights to pharma entrepreneurs and distributors across India, backed by DCGI-approved quality and a reliable supply chain.
What is Cefprozil?
Cefprozil is a second-generation cephalosporin antibiotic that kills bacteria by interfering with the synthesis of the bacterial cell wall. It is a prescription-only antibiotic and should be used only under qualified medical supervision to support responsible antibiotic use. Read the compound profile on PubChem.
Available Cefprozil Formulations
Cafoli Lifecare offers 4 Cefprozil formulations for franchise partners. Available forms: Dry Syrup, Tablets. Every batch is manufactured at WHO-GMP certified facilities and supplied with full regulatory documentation. Pricing is shared on request.
Therapeutic Applications
Cefprozil is used to treat bacterial infections of the respiratory tract, ear, throat and skin. It is prescribed mainly by general physicians, paediatricians and ENT specialists.
Why Cefprozil is a High-Potential Molecule for Distributors
Broad-spectrum oral cephalosporins see high prescription volume across acute care, and the paediatric dry syrup form widens reach into childrens infections, giving Cefprozil strong turnover in both adult and child segments.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved products, attractive promotional inputs and dedicated marketing support to a growing network of 1000+ franchise partners across India. Our focus on quality and on-time supply makes us a preferred Cefprozil franchise partner.
References
- PubChem: Cefprozil
- PubMed research on Cefprozil
Our formulations of Cefprozil find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: